AstraZeneca
The Director, Payer Engagement at AstraZeneca Canada is a senior leadership role focused on payer engagement and improving public reimbursement pathways for oncology and biopharmaceutical products. The position represents AstraZeneca to healthcare system stakeholders across Canada and leads a national customer-facing team. It supports the company’s goal of increasing patient access to innovative medicines.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
Payer Engagement Lead, National Accounts
Praxis Precision Medicines, Inc.
National Account Director, Payer (United/Optum/Emisar)
Revolution Medicines
Director, Payer Policy
NeoGenomics Laboratories
Director, Advanced Cellular Therapies (Payer Strategy)
McKesson
National Account Executive
Genetix Biotherapeutics
Associate Director, US Oncology Payer Market Access
MSD